Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;172(3):997-1004.
doi: 10.1016/j.surg.2022.04.033. Epub 2022 Jul 10.

Greater community vulnerability is associated with poor living donor navigator program fidelity

Affiliations

Greater community vulnerability is associated with poor living donor navigator program fidelity

A Cozette Killian et al. Surgery. 2022 Sep.

Abstract

Background: Community-level factors contribute to living donor kidney transplantation disparities but may also influence the interventions aimed to mitigate these disparities. The Living Donor Navigator Program was designed to separate the advocacy role from the patient in need of transplantation-friends/family are encouraged to participate as the patients' advocates to identify living donors, though some of the patients participate alone as self-advocates. Self-advocates have a lower living donor kidney transplantation likelihood compared to the patients with an advocate. We sought to evaluate the relationship between the patients' community-level vulnerability and living donor navigator self-advocacy as a surrogate for program fidelity.

Methods: This single-center, retrospective study included 110 Living Donor Navigator participants (April 2017-June 2019). Program fidelity was assessed using the participants' advocacy status. Measures of community vulnerability were obtained from the Centers for Disease Control and Prevention Social Vulnerability Index. Modified Poisson regression was used to evaluate the association between community-level vulnerability and living donor navigator self-advocacy.

Results: Of the 110 participants, 19% (n = 21) were self-advocates. For every 10% increase in community-level vulnerability, patients had 17% higher risk of self-advocacy (adjusted relative risk 1.17, 95% confidence interval: 1.03-1.32, P = .01). Living in areas with greater unemployment (adjusted relative risk: 1.18, 95% confidence interval: 1.04-1.33, P = .01), single-parent households (adjusted relative risk: 1.23, 95% confidence interval: 1.06-1.42, P = .006), minority population (adjusted relative risk: 1.30, 95% confidence interval: 1.04-1.55, P = .02), or no-vehicle households (adjusted relative risk: 1.17, 95% confidence interval: 1.02-1.35, P = .02) were associated with increased risk of self-advocacy.

Conclusion: Having a greater community-level vulnerability was associated with poor Living Donor Navigator Program fidelity. The potential barriers identified using the Social Vulnerability Index may direct resource allocation and program refinement to optimize program fidelity and efficacy for all participants.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST AND DISCLOSURES STATEMENT

A. Cozette Killian reports salary support from the NIH T32 and Resident Research Fellowship Award from the American College of Surgeons (both listed below under Funding/Financial Support).

Alexis J. Carter reports no biomedical financial interests or potential conflicts of interest.

Rhiannon D. Reed reports salary support from a grant funded by United Therapeutics.

Brittany A. Shelton reports no biomedical financial interests or potential conflicts of interest.

Haiyan Qu reports no biomedical financial interests or potential conflicts of interest.

M. Chandler McLeod reports no biomedical financial interests or potential conflicts of interest.

Babak J. Orandi reports salary support from a grant funded by United Therapeutics.

Robert M. Cannon reports no biomedical financial interests or potential conflicts of interest.

Douglas Anderson reports no biomedical financial interests or potential conflicts of interest.

Paul A. MacLennan reports no biomedical financial interests or potential conflicts of interest.

Vineeta Kumar reports no biomedical financial interests or potential conflicts of interest.

Michael Hanaway reports no biomedical financial interests or potential conflicts of interest.

Jayme E. Locke reports grant funding from the NIH and United Therapeutics, honoraria from Sanofi and Novartis, clinical trial with Hansa, and non-monetary relationships with the FDA and DaVita.

Figures

Figure 1.
Figure 1.
Predicted probability curve for Living Donor Navigator Program self-advocacy as a function of overall Social Vulnerability Index (SVI) using a modified Poisson regression model. Shaded area represents 95% confidence limits. Model is fit for a 53-year-old, non-Black, male participant who does not live alone. Model adjusted for recipient age, gender, race, and whether the recipient lives alone
Figure 2.
Figure 2.
Jefferson County census tract-level map of community vulnerability factors and Living Donor Navigator participants’ (04/2017-06/2019) residences by self-advocacy status (N=53). Self-advocates are demonstrated by red dots, while patients with an advocate are demonstrated by yellow dots. Lighter shades of color on the map denote lower social vulnerability, while darker shades of color denote higher social vulnerability with regard to each community vulnerability factor: Figure 2A – Unemployment; Figure 2B – Minority Status; Figure 2C – Single-Parent Household; Figure 2D – No-Vehicle Household.

Comment in

References

    1. Orandi BJ, Luo X, Massie AB, Garonzik-Wang JM, Lonze BE, Ahmed R, et al. Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors. N Engl J Med. 2016;374:940–50. - PMC - PubMed
    1. Purnell TS, Luo X, Cooper LA, Massie AB, Kucirka LM, Henderson ML, et al. Association of Race and Ethnicity With Live Donor Kidney Transplantation in the United States From 1995 to 2014. JAMA. 2018;319:49–61. - PMC - PubMed
    1. Purnell T, Xu P, Leca N, Hall Y. Racial differences in determinants of live donor kidney transplantation in the United States. American Journal of transplantation. 2013;13:1557–65. - PMC - PubMed
    1. Gore JL, Danovitch GM, Litwin MS, Pham PT, Singer JS. Disparities in the utilization of live donor renal transplantation. Am J Transplant. 2009;9:1124–33. - PubMed
    1. Killian AC, Shelton B, MacLennan P, McLeod MC, Carter A, Reed R, et al. Evaluation of Community-Level Vulnerability and Racial Disparities in Living Donor Kidney Transplant. JAMA Surg. 2021;156:1120–9. - PMC - PubMed

Publication types

LinkOut - more resources